These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4799943)

  • 41. [Qualitative analysis of the main urinary metabolites of dopamine, epinephrine and norepinephrine by gas chromatography].
    Bègue RJ; Bazerolle O; Desgres J; Lallemant C; Padieu P
    Pathol Biol (Paris); 1971; 19(15):719-25. PubMed ID: 4942503
    [No Abstract]   [Full Text] [Related]  

  • 42. Predicting the response to levodopa.
    Van Woert MH; Weintraub MI
    Lancet; 1971 May; 1(7707):1015-6. PubMed ID: 4102426
    [No Abstract]   [Full Text] [Related]  

  • 43. Tyrosinosis: a patient without liver or renal disease.
    Holston JL; Levy HL; Tomlin GA; Atkins RJ; Patton TH; Hosty TS
    Pediatrics; 1971 Sep; 48(3):393-400. PubMed ID: 5094340
    [No Abstract]   [Full Text] [Related]  

  • 44. Plasma 3-0-methyldopa in L-dopa therapy of Parkinson's disease.
    Muenter MD; Sharpless NS; Tyce GM
    Mayo Clin Proc; 1972 Jun; 47(6):389-95. PubMed ID: 5041685
    [No Abstract]   [Full Text] [Related]  

  • 45. Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor.
    Papavasiliou PS; Cotzias GC; Düby SE; Steck AJ; Fehling C; Bell MA
    N Engl J Med; 1972 Jan; 286(1):8-14. PubMed ID: 4550085
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of Parkinsonism with L-dopa--with special reference to clinical effects, side effects and urinary metabolites of catecholamines].
    Uono M; Tanabe H; Yano Y; Nakao K
    No To Shinkei; 1970 Sep; 22(9):1091-101. PubMed ID: 5536082
    [No Abstract]   [Full Text] [Related]  

  • 47. Gas chromatography of some urinary acid metabolites related to phenylketonuria.
    Hoffman NE; Gooding KM
    Anal Biochem; 1969 Oct; 31(1):471-9. PubMed ID: 5380714
    [No Abstract]   [Full Text] [Related]  

  • 48. Levodopa.
    Lancet; 1971 Sep; 2(7723):533. PubMed ID: 4105672
    [No Abstract]   [Full Text] [Related]  

  • 49. Assay, properties and tissue distribution of p-hydroxyphenylpyruvate hydroxylase.
    Fellman JH; Fujita TS; Roth ES
    Biochim Biophys Acta; 1972 Sep; 284(1):90-100. PubMed ID: 4627454
    [No Abstract]   [Full Text] [Related]  

  • 50. Oxidation of alcohols by Botrytis cinerea.
    Fukuda DS; Brannon DR
    Appl Microbiol; 1971 Mar; 21(3):550-1. PubMed ID: 5102778
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Determination of homoprotocatechic acid in urine by a radioisotopic method].
    Comoy E; Bohuon C
    Clin Chim Acta; 1972 Jan; 36(1):207-12. PubMed ID: 5007702
    [No Abstract]   [Full Text] [Related]  

  • 52. Pyridoxine antagonism of levodopa in parkinsonism.
    Leon AS; Spiegel HE; Thomas G; Abrams WB
    JAMA; 1971 Dec; 218(13):1924-7. PubMed ID: 5171069
    [No Abstract]   [Full Text] [Related]  

  • 53. Parkinsonism and DOPA.
    Cotzias GC; Papavasiliou PS; Gellene R; Aronson RB
    Trans Assoc Am Physicians; 1968; 81():171-83. PubMed ID: 4889342
    [No Abstract]   [Full Text] [Related]  

  • 54. Absence of response to levodopa in Parkinson's disease.
    Mones RJ
    JAMA; 1971 Aug; 217(9):1245. PubMed ID: 5109470
    [No Abstract]   [Full Text] [Related]  

  • 55. Excretion of dopa metabolites.
    Kott E; Bornstein B; Eichhorn F
    N Engl J Med; 1971 Feb; 284(7):395. PubMed ID: 5539935
    [No Abstract]   [Full Text] [Related]  

  • 56. Oxidative decomposition by an aerobacter cloacae mutant of L-tyrosine.
    Hamasaki S; Uchida M
    Kumamoto Med J; 1967 Dec; 20(4):163-7. PubMed ID: 5586196
    [No Abstract]   [Full Text] [Related]  

  • 57. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
    Pullar IA; Dowson JH; Ahmed R; Chow R; Gillingham FJ
    Confin Neurol; 1972; 34(2):143-8. PubMed ID: 4666057
    [No Abstract]   [Full Text] [Related]  

  • 58. [Dopaminergic conception of Parkinsonism and its treatment with L-DOPA].
    Levin SL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(9):1418-26. PubMed ID: 4349303
    [No Abstract]   [Full Text] [Related]  

  • 59. [The effect of alpha-DOPA on the dynamics of urinary excretion of DOPA, catecholamines and their metabolites in healthy subjects and in patients with parkinsonism].
    Matlina ESh; Kandel' EI; Vasil'ev VN; Iadgarov IS; Bol'shakova TD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):205-9. PubMed ID: 4743269
    [No Abstract]   [Full Text] [Related]  

  • 60. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
    Pullar IA; Dowson JH; Ahmed R; Chow R; Gillingham FJ
    Confin Neurol; 1972; 34(1):143-8. PubMed ID: 5084388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.